Patent details

Basic Information

Publication number:

EP1087778

PCT Application Number:

PCT/EP/1999/003746

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP999278047

PCT Publication Number:

WO/1999/064016

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C

French Title of Invention:

UTILISATION DE PEG-IFN-ALPHA ET DE RIBAVIRINE POUR TRAITER L'HEPATITE C CHRONIQUE

German Title of Invention:

VERWENDUNG VON PEG-IFN-ALPHA UND RIBAVIRIN ZUR BEHANDLUNG CHRONISCHER HEPATITIS C

SPC Number:

Dates

Filing date:

29/05/1999

Grant date:

26/10/2005

EP Publication Date:

26/10/2005

PCT Publication Date:

16/12/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/04/2001

EP B1 Publication Date:

26/10/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/05/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/05/1999

 

 

Name:

F. HOFFMANN-LA ROCHE AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

26/10/2005

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

ZAHM Friederike

Address:

Germany (DE)

Priority

Priority Number:

98110433

Priority Date:

08/06/1998

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/70;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

07/05/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages